Jan. 6, 2023 — The highly anticipated Alzheimer’s drug lecanemab was granted accelerated approval status this afternoon by the FDA, offering hope where there has been little for patients and their families affected by the devastating disease.More than 6 million people in the U.S. live with…
Source: www.webmd.com – Read more
Noodlophile Malware Campaign Expands Global Reach with Copyright Phishing Lures
The threat actors behind the Noodlophile malware are leveraging spear-phishing emails and updated delivery mechanisms to deploy the information stealer in attacks aimed at enterprises
